Academic Journal

Effects of electroconvulsive therapy on cerebellar-cerebral functional connectivity in patients with treatment-resistant depression and their correlations with gene expression profiles.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Effects of electroconvulsive therapy on cerebellar-cerebral functional connectivity in patients with treatment-resistant depression and their correlations with gene expression profiles.
Συγγραφείς: Zhang L; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Han Y; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Lv D; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China., Yao P; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China., Chen L; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China., Yuan Y; Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China., Zhao J; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Guo W; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Guo Z; Inner Mongolia Autonomous Region Mental Health Center, Hohhot, Inner Mongolia Autonomous Region, China., Ou Y; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Πηγή: Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2026 Aug; Vol. 80 (8), pp. 655-664. Date of Electronic Publication: 2026 May 07.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9513551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1819 (Electronic) Linking ISSN: 13231316 NLM ISO Abbreviation: Psychiatry Clin Neurosci Subsets: MEDLINE
Imprint Name(s): Original Publication: Carlton, Vic., Australia : Blackwell Science
Ιατρικοί όροι (MeSH): Depressive Disorder, Treatment-Resistant*/therapy , Depressive Disorder, Treatment-Resistant*/diagnostic imaging , Depressive Disorder, Treatment-Resistant*/physiopathology , Depressive Disorder, Treatment-Resistant*/genetics , Cerebellum*/diagnostic imaging , Cerebellum*/physiopathology , Nerve Net*/physiopathology , Nerve Net*/diagnostic imaging , Cerebral Cortex*/diagnostic imaging , Cerebral Cortex*/physiopathology , Default Mode Network*/diagnostic imaging , Default Mode Network*/physiopathology , Electroconvulsive Therapy* , Connectome* , Transcriptome*, Humans ; Female ; Male ; Adult ; Middle Aged ; Magnetic Resonance Imaging
Περίληψη: Aims: Electroconvulsive therapy (ECT) is an effective intervention for treatment-resistant depression (TRD). Although prior studies have identified cerebellar functional alterations following ECT, cerebellar-cerebral functional connectivity (FC) changes remain insufficiently explored.
Methods: Cerebellar seeds were defined based on prior connectivity studies, targeting cerebellar regions functionally coupled with executive, default-mode, and affective-limbic networks. Seed-based cerebellar-cerebral FC analyses were conducted using neuroimaging data from 72 patients with TRD (52 of whom completed post-ECT assessment) and 63 healthy controls (HCs). Correlation analyses assessed clinical associations, and support vector regression was applied to predict treatment response using baseline FC. Neuroimaging-transcriptomic association analyses were conducted to identify gene expression patterns correlated with post-ECT FC alterations.
Results: Compared to HCs, patients with TRD exhibited decreased cerebellar connectivity with the sensorimotor network (SMN) and the default-mode network (DMN). Following ECT, TRD patients showed significant alleviation of depressive symptoms, which was accompanied by a marked increase in cerebellar-DMN connectivity. Enhanced FCs between the left Crus IIExec2 and the bilateral medial superior frontal gyrus were positively correlated with Hamilton Depression Rating Scale (HAMD) score reduction (r = 0.343, P = 0.026). Additionally, baseline FC of the left Crus IIExec2 significantly predicted HAMD reduction (r = 0.412, P < 0.001). Neuroimaging-transcription association analysis revealed these FC alterations were associated with normative gene patterns enriched in synaptic signaling, ion channel, and chromatin remodeling.
Conclusions: TRD is associated with reduced cerebellar-SMN and cerebellar-DMN connectivity. ECT may enhance cerebellar-DMN connectivity, potentially contributing to antidepressant effects.
(© 2026 The Author(s). Psychiatry and Clinical Neurosciences © 2026 Japanese Society of Psychiatry and Neurology.)
References: Front Neurosci. 2020 Jul 08;14:545. (PMID: 32742251)
Psychiatry Res. 2020 Dec;294:113461. (PMID: 33038791)
Psychoneuroendocrinology. 2025 Jul;177:107472. (PMID: 40288014)
Neurosci Biobehav Rev. 2022 Jan;132:433-448. (PMID: 34890601)
Am J Psychiatry. 2011 Jun;168(6):642-8. (PMID: 21362744)
Neurosci Lett. 2011 Apr 15;493(3):122-6. (PMID: 21335060)
Hum Brain Mapp. 2019 Feb 1;40(2):465-473. (PMID: 30240504)
CNS Drugs. 2009 Aug;23(8):627-47. (PMID: 19594193)
Brain Imaging Behav. 2020 Jun;14(3):753-761. (PMID: 30610527)
PLoS One. 2012;7(9):e45263. (PMID: 23028892)
J Affect Disord. 2025 Jun 15;379:615-623. (PMID: 40044090)
Sci Bull (Beijing). 2019 Jul 30;64(14):953-954. (PMID: 36659803)
Psychol Med. 2019 Jun;49(8):1357-1364. (PMID: 30229715)
J ECT. 2002 Mar;18(1):58-9. (PMID: 11925524)
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Feb 6;73:31-35. (PMID: 27665684)
Psychiatry Res. 2024 Apr;334:115817. (PMID: 38430816)
J Neuropsychiatry Clin Neurosci. 2004 Summer;16(3):367-78. (PMID: 15377747)
Nat Neurosci. 2009 May;12(5):547-8. (PMID: 19363489)
Cerebellum. 2012 Jun;11(2):352-65. (PMID: 21373864)
J Affect Disord. 2019 Jan 1;242:195-210. (PMID: 30195173)
Transl Psychiatry. 2025 Mar 17;15(1):86. (PMID: 40097427)
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:168-84. (PMID: 23268191)
Brain. 2009 Apr;132(Pt 4):999-1012. (PMID: 19339252)
Prev Sci. 2011 Dec;12(4):361-71. (PMID: 21732121)
Front Psychiatry. 2015 Mar 02;6:28. (PMID: 25784881)
Cerebellum. 2007;6(3):254-67. (PMID: 17786822)
J Affect Disord. 2025 Apr 01;374:495-502. (PMID: 39824319)
Can J Psychiatry. 2019 Jun;64(6):380-387. (PMID: 30763119)
Brain Stimul. 2017 May - Jun;10(3):637-644. (PMID: 28162976)
Commun Biol. 2019 Oct 10;2:370. (PMID: 31633061)
Signal Transduct Target Ther. 2023 Aug 30;8(1):309. (PMID: 37644009)
Transl Psychiatry. 2025 Apr 02;15(1):117. (PMID: 40175334)
Psychophysiology. 1979 Nov;16(6):495-512. (PMID: 515293)
Nature. 2012 Sep 20;489(7416):391-399. (PMID: 22996553)
Hum Brain Mapp. 2018 Mar;39(3):1403-1411. (PMID: 29266749)
MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):644-650. (PMID: 37318995)
Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jan 10;120:110621. (PMID: 36031163)
J Affect Disord. 2019 Feb 1;244:92-99. (PMID: 30326347)
Ann N Y Acad Sci. 2014 May;1316:29-52. (PMID: 24502540)
J ECT. 2012 Dec;28(4):234-41. (PMID: 22820953)
Sci Rep. 2019 Mar 25;9(1):5071. (PMID: 30911075)
Hum Psychopharmacol. 2016 May;31(3):247-51. (PMID: 27062668)
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12562-12567. (PMID: 27791098)
J Affect Disord. 2020 Oct 1;275:319-328. (PMID: 32734925)
Neuroscience. 2015 Jul 9;298:329-35. (PMID: 25907440)
Transl Psychiatry. 2018 Mar 6;8(1):57. (PMID: 29507282)
World J Psychiatry. 2022 May 19;12(5):708-721. (PMID: 35663299)
Epilepsia. 2015 Mar;56(3):382-92. (PMID: 25631544)
PLoS One. 2011;6(5):e20035. (PMID: 21637831)
J Neurol Sci. 2022 Mar 15;434:120095. (PMID: 34979372)
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:51-7. (PMID: 23352887)
J ECT. 2016 Mar;32(1):49-54. (PMID: 26252558)
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110178. (PMID: 33197507)
PLoS One. 2012;7(6):e39516. (PMID: 22724025)
Psychiatry Res. 2023 Jun;324:115192. (PMID: 37054552)
J Psychiatr Res. 2016 Nov;82:30-9. (PMID: 27459030)
Am J Psychiatry. 2006 Nov;163(11):1905-17. (PMID: 17074942)
Eur Neuropsychopharmacol. 2019 Aug;29(8):925-935. (PMID: 31279591)
Mol Psychiatry. 2015 May;20(5):609-14. (PMID: 25092248)
J Pain. 2010 Mar;11(3):287-90. (PMID: 19944649)
CNS Neurosci Ther. 2024 Mar;30(3):e14690. (PMID: 38529527)
Int J Psychophysiol. 2009 Apr;72(1):46-50. (PMID: 18824045)
J Neurosci. 2009 Jul 1;29(26):8586-94. (PMID: 19571149)
Cereb Cortex. 2009 Oct;19(10):2485-97. (PMID: 19592571)
Grant Information: 82171508 National Natural Science Foundation of China; 2025JJ60706 Natural Science Foundation of Hunan Province
Contributed Indexing: Keywords: cerebellum; functional connectivity; neuroimaging–transcription association analysis; the default‐mode network; treatment‐resistant depression
Entry Date(s): Date Created: 20260508 Date Completed: 20260806 Latest Revision: 20260813
Update Code: 20260813
PubMed Central ID: PMC13447124
DOI: 10.1111/pcn.70071
PMID: 42099010
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1440-1819
DOI:10.1111/pcn.70071